ARTICLE | Company News
CAT accesses Incyte's LifeSeq
December 19, 2001 8:00 AM UTC
Cambridge Antibody Technology (LSE:CAT; CATG) received access to INCY's LifeSeq Gold database and sequence-verified cDNA clones. In addition, CAT has an option to receive exclusive licenses to discove...